Samsung Bioepis Co., Ltd. v. Regeneron Pharmaceuticals, Inc. > Summary
Court Case Number IPR2023-00442
Filing Date Jan 6, 2023
Court Patent Trial and Appeal Board
Status Trial Instituted
Administrative JudgesJohn G. New, Erica A. Franklin, Susan L. C. Mitchell
Judge Writing the Final DecisionJohn G. New
Claims Challenged in the Petition: 1, 8, 9, 10, 11, 12
Petitioner
Patent Owner
Petitioner Attorneys
8Regeneron Pharmaceuticals
Attorney Name: Landon A. Smith
Quinn Emanuel Urquhart & Sullivan
Regeneron Pharmaceuticals
Attorney Name: Matthew A. Traupman
Quinn Emanuel Urquhart & Sullivan
Regeneron Pharmaceuticals
Quinn Emanuel Urquhart & Sullivan
Attorney Name: Razmig H. Messerian
Quinn Emanuel Urquhart & Sullivan
Attorney Name: Elliot Choi
Quinn Emanuel Urquhart & Sullivan
Attorney Name: Zachariah Summers
Quinn Emanuel Urquhart & Sullivan
Attorney Name: Sarah Marianne Cork
Quinn Emanuel Urquhart & Sullivan
Patent Owner Attorneys
9samsung bioepis
Attorney Name: Alice Ho
Arnold & Porter Kaye Scholer
samsung bioepis
Attorney Name: Victoria Reines
Arnold & Porter Kaye Scholer
samsung bioepis
Attorney Name: Jeremy D. Cobb
Arnold & Porter Kaye Scholer
samsung bioepis
Attorney Name: Abigail Struthers
Arnold & Porter Kaye Scholer
samsung bioepis
Attorney Name: Daniel L. Reisner
Arnold & Porter Kaye Scholer
samsung bioepis
Attorney Name: Matthew Wilk
Arnold & Porter Kaye Scholer
samsung bioepis
Attorney Name: David A. Caine
Arnold & Porter Kaye Scholer
samsung bioepis
Attorney Name: David S. Denuyl
Arnold & Porter Kaye Scholer
Attorney Name: Deborah E. Fishman
Arnold & Porter Kaye Scholer
Related Patents
| Doc No | Title | Issue date |
|---|---|---|
| 10130681 | Use of a VEGF antagonist to treat angiogenic eye disorders | Nov 20, 2018 |
